Search News
| 169.23 Delayed Data As of Jul 20 |  +5.12 / +3.12%Today’s Change | 65.58 Today|||52-Week Range 220.10 | +73.18% Year-to-Date |
| Previous close | 164.11 |
| Today’s open | 165.12 |
| Day’s range | 164.29 - 172.92 |
| Volume | 279,252 |
| Average volume (3 months) | 355,526 |
| Market cap | $9.1B |
| Earnings growth (last year) | +43.03% |
| Earnings growth (this year) | -233.28% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +22,299.66% |
| P/E ratio | NM |
| Price/Sales | 17.07 |
| Price/Book | 11.51 |
| Today’s change | Today’s % change | |
|---|---|---|
| TYMETyme Technologies In... | -0.07 | -2.35% |
| OASMOasmia Pharmaceutica... | -0.13 | -8.26% |
| TEVATeva Pharmaceutical | -0.13 | -0.56% |
| Next reporting date | August 9, 2018 |
| EPS forecast (this quarter) | -$2.02 |
| Annual revenue (last year) | $239.2M |
| Annual profit (last year) | -$93.4M |
| Net profit margin | -39.06% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer John V. Oyler |
President Xiao Bin Wu |
Corporate headquarters Beijing, Beijing |
